完全肾脏缓解的狼疮肾炎患者妊娠结局良好
本研究回顾性分析了155例狼疮肾炎(LN)患者的158次妊娠,按孕前是否达到完全肾脏缓解(CRR)分为缓解组和对照组。缓解组活产率更高,LN复发、胎儿丢失和早产发生率显著更低。CRR持续时间<18个月和抗C1q抗体阳性是LN复发的独立危险因素,抗磷脂抗体阳性和妊娠期泼尼松剂量≥12.5 mg/天分别与胎儿丢失和早产独立相关,年龄>30岁是子痫前期和早产的独立危险因素。
要点
- 孕前达到完全肾脏缓解可显著降低LN复发、胎儿丢失和早产风险。
- CRR持续<18个月和抗C1q抗体阳性是LN复发的独立危险因素。
- 抗磷脂抗体阳性与胎儿丢失相关,妊娠期泼尼松≥12.5 mg/天与早产相关。
核心结论
- LN患者CRR持续时间>18个月与良好妊娠结局和较低LN复发相关。
- 年龄、抗C1q抗体、抗磷脂抗体及妊娠期泼尼松剂量是不良妊娠结局的危险因素。
研究设计与样本
- 回顾性分析155例LN患者的158次妊娠,分为缓解组(133次妊娠)和对照组(25次妊娠)。
主要发现
- 缓解组133次妊娠分娩127例活产,对照组25次妊娠分娩19例活产。
- 缓解组LN复发、胎儿丢失和早产发生率显著低于对照组。
- 缓解组中CRR持续时间<18个月(OR 11.24,95%CI 2.95-42.80,P<0.001)和孕前抗C1q抗体阳性(OR 7.2,95%CI 1.38-37.41,P=0.019)是LN复发的独立危险因素。
- 抗磷脂抗体阳性(OR 9.32,95%CI 1.27-68.27,P=0.028)是胎儿丢失的独立危险因素,妊娠期泼尼松剂量≥12.5 mg/天(OR 3.88,95%CI 1.37-10.99,P=0.011)是早产的独立危险因素。
- 年龄>30岁是子痫前期和早产的独立危险因素。
临床怎么用
- 对计划妊娠的LN患者应评估是否达到完全肾脏缓解并尽量维持>18个月。
- 孕前检测抗C1q抗体和抗磷脂抗体,妊娠期尽量控制泼尼松剂量<12.5 mg/天。
- 年龄>30岁的LN孕妇需警惕子痫前期和早产。
局限性
- 回顾性研究设计。
- 对照组样本量较小(25次妊娠)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study was to investigate pregnancy outcomes and risk factors in patients with lupus nephritis (LN). METHODS: A total of 158 pregnancies in 155 women with LN were divided into a remission group and a control group according to whether they achieved complete renal remission (CRR) prior to pregnancy. The adverse pregnancy outcomes and risk factors were retrospectively analyzed. RESULTS: In the remission group, 130 LN patients with 133 pregnancies (two twin pregnancies) delivered 127 live births; 25 LN patients with 25 pregnancies delivered 19 live births in the control group. Compared with the control group, the remission group had significantly lower incidence of LN relapse, fetal loss and premature birth. For LN patients in the remission group, a CRR duration <18 months [odds ratio (OR) 11.24, 95% confidence interval (CI) 2.95-42.80, P < 0.001] and anti-C1q antibody positivity before pregnancy (OR 7.2, 95% CI 1.38-37.41, P = 0.019) were independent risk factors for LN relapse; anti-phospholipid antibody positivity (OR 9.32, 95% CI 1.27-68.27, P = 0.028) and prednisone dosage during pregnancy ≥12.5 mg/day (OR 3.88, 95% CI 1.37-10.99, P = 0.011) were independent risk factors for fetal loss and premature birth, respectively; and age >30 years was an independent risk factor for preeclampsia and premature birth. CONCLUSION: LN patients with a CRR duration greater than 18 months were associated with good pregnancy outcomes and lower LN relapse. Age, anti-C1q and anti-phospholipid antibodies, and prednisone dosage during pregnancy were risk factors for adverse pregnancy outcomes.
引用
- Chen Y, Li K, Zhang H, et al. Good pregnancy outcomes in lupus nephritis patients with complete renal remission. Nephrol Dial Transplant. 2022. PMID: 34610132. doi:10.1093/ndt/gfab289
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。